Cost effectiveness analysis of immunotherapy regimens currently approved in advanced or recurrent endometrial cancer: An analysis of the NRG-GY 018, RUBY, and DUO-E trials
Listen to this summary
The authors aimed to evaluate the cost-effectiveness of FDA-approved immunotherapy regimens combined with chemotherapy for advanced or recurrent endometrial cancer, specifically in mismatch repair deficient (dMMR) and proficient (pMMR) cohorts. Their analysis revealed that pembrolizumab and durvalumab are more cost-effective than dostarlimab, primarily due to differences in maintenance therapy duration, while immunotherapy appears less cost-effective for the pMMR population.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.
More from Gynecologic oncology reports
View all →Mar 20, 2026 · Gynecologic oncology reports
Patient perspectives on post-operative direct oral anticoagulant for venous thromboembolism prevention in patients with gynecologic cancers undergoing laparotomy
Mar 19, 2026 · Gynecologic oncology reports
Neoadjuvant chemotherapy in locally advanced clear cell carcinoma of the cervix leading to complete disease resolution; a case report
Mar 11, 2026 · Gynecologic oncology reports
Unilateral cervical carcinoma in a septate uterus with double cervix: A case report and literature review
Mar 9, 2026 · Gynecologic oncology reports
Sentinel node technologies in low-resource settings: Current evidence and future perspectives
Mar 5, 2026 · Gynecologic oncology reports
Radiation-specific sexual and reproductive health challenges in adolescent and young adults assigned female at birth: a mixed-methods study of unmet needs post pelvic radiotherapy
Mar 5, 2026 · Gynecologic oncology reports
Highlighting the molecular refinement of NSMP endometrial cancer in a case of mesonephric-like adenocarcinoma
More in Obstetrics & Gynecology
View all →Mar 25, 2026 · Journal of minimally invasive gynecology
Pain severity and Magnetic Resonance Imaging as key factors in the management of accessory cavitated uterine malformation
Mar 25, 2026 · The New England journal of medicine
A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide
Mar 25, 2026 · Contraception
Reasons for contraceptive nonuse at two sites in Burkina Faso
Mar 25, 2026 · American journal of obstetrics & gynecology MFM
Factors associated with appropriate administration of magnesium sulfate for neuroprotection prior to early preterm birth
Mar 25, 2026 · BJOG : an international journal of obstetrics and gynaecology
Effectiveness of Interventions to Improve Women's Experience of Pelvic Examinations: A Systematic Review and Meta-Analysis
Mar 24, 2026 · Human reproduction (Oxford, England)
Human stem cell-based embryo models: innovation, ethics, and policy
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR
Stay current without falling behind
33,000+ journals. 3-minute audio summaries. Free for 14 days.
